Co-administration of GP96 and Her2/neu DNA vaccine in a Her2 breast cancer model

Cell Stress and Chaperones

Volumn 15, Issue 6, 2010, Pages 977-984

  Pakravan, Nafiseh ^a   Langroudi, Ladan ^a   Hajimoradi, Monire ^a   Hassan, Zuhair Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Co administration; DNA vaccine; GP96; Her2; Regulatory T cells

Indexed keywords

DNA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON; GLYCOPROTEIN GP 96; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GENE THERAPY; CANCER IMMUNIZATION; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; EXPRESSION VECTOR; FEMALE; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE;

ANIMALS; CANCER VACCINES; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; RECEPTOR, ERBB-2; T-LYMPHOCYTES, REGULATORY; VACCINES, DNA;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 78149468369     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-010-0208-8     Document Type: Article

References (30)

1. A Asea E Kabingu MA Stevenson SK Calderwood 2000 HSP70 peptidembearing and peptide-negative preparations act as chaperokines Cell Stress Chaperones 5 425 431 1:CAS:528:DC%2BD3MXkslygtA%3D%3D 10.1379/1466-1268(2000)005<0425: HPBAPN>2.0.CO;2 11189447 (Pubitemid 32057493)
2. JC Baker-LePain M Sarzotti CV Nicchitta 2004 Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo J Immunol 172 4195 4203 1:CAS:528:DC%2BD2cXitlOqsb8%3D 15034032
3. RJ Binder 2008 Heat-shock protein-based vaccines for cancer and infectious disease Expert Rev Vaccine 7 383 393 1:CAS:528:DC%2BD1cXktlahur4%3D 10.1586/14760584.7.3.383 (Pubitemid 351520026)
4. A Bolhassani F Zahedifard M Taghikhani S Rafati 2008 Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies Vaccine 26 3362 3370 1:CAS:528:DC%2BD1cXnt1Smurk%3D 10.1016/j.vaccine.2008.03.082 18471945
5. M Chalfie Y Tu G Euskirchen WW Ward DC Prasher 1994 Green fluorescent protein as a marker for gene expression Science 263 802 805 1:CAS:528: DyaK2cXitFWkurc%3D 10.1126/science.8303295 8303295
6. L Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 1:CAS:528:DC%2BD38XpsFygtb4%3D 10.1038/nature01322 12490959 (Pubitemid 36019639)
7. C Curcio E Di Carlo R Clynes MJ Smyth K Boggio E Quaglino, et al. 2003 Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas J Clin Invest 111 1161 1170 1:CAS:528:DC%2BD3sXjtFCrs74%3D 12697735
8. JS Dela Cruz SL Morrison ML Penichet 2005 Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein Vaccine 23 4793 4803 1:CAS:528:DC%2BD2MXpsVWgsLs%3D 10.1016/j.vaccine. 2005.04.041 15967544 (Pubitemid 41557330)
9. YF He XH Wang GM Zhang HT Chen H Zhang ZH Feng 2005 Sustained low-level expression of interferon-g promotes tumor development: potential insights in tumor prevention and tumor immunotherapy Cancer Immunol Immunother 54 891 897 1:CAS:528:DC%2BD2MXlvVynsrk%3D 10.1007/s00262-004-0654-1 15776283 (Pubitemid 40991331)
10. T Ishikawa M Kobayashi M Mai T Suzuki A Ooi 1997 Amplification of the c-erbB-2 (Her-2/neu) gene in gastric cancer cells Am J Pathol 151 761 768 1:CAS:528:DyaK2sXmt1Squr8%3D 9284825
11. JH Kim N Majumder H Lin J Chen LD Falo Jr Z You 2005 Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer Mol Ther 11 941 949 1:CAS:528:DC%2BD2MXks1ajsbc%3D 10.1016/j.ymthe.2005.01.003 15922965 (Pubitemid 40724113)
12. M Kmieciak KL Knutson CI Dumur MH Manjili 2007 HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses Eur J Immunol 37 675 685 1:CAS:528:DC%2BD2sXjs1Sjsbo%3D 10.1002/eji.200636639 17304628 (Pubitemid 46916934)
13. CC Lin CW Chou AL Shiau CF Tu TM Ko YL Chen, et al. 2004 Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu Mol Ther 10 290 301 1:CAS:528:DC%2BD2cXmt1Cms70%3D 10.1016/j.ymthe.2004.05. 015 15294176 (Pubitemid 39117874)
14. Z Liu X Li L Qiu X Zhang L Chen S Cao, et al. 2009 Treg suppress CTL responses upon immunization with HSP gp96 Eur J Immunol 39 3110 3120 1:CAS:528:DC%2BD1MXhsFWhtbbO 10.1002/eji.200939593 19839010
15. ME Lutsiak Y Tagaya AJ Adams J Schlom H Sabzevari 2008 Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells Immunol 180 5871 5881 1:CAS:528: DC%2BD1cXkvVCjsrk%3D
16. MH Manjili XY Wang X Chen T Martin EA Repasky R Henderson, et al. 2003 HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice J Immunol 171 4054 4061 1:CAS:528:DC%2BD3sXnvVOksLc%3D 14530326
17. Y Nagata R Furugen A Hiasa H Ikeda N Ohta K Furukawa, et al. 1997 Peptides derived from a wild-type murine protooncogene c-erbB-2/HER2/2 neu can induce CTL and tumor suppression in syngeneic hosts J Immunol 159 1336 1343 1:CAS:528:DyaK2sXkslKntLw%3D 9233630
18. CV Nicchitta 2003 Re-evaluating the role of heat-shock protein peptide interactions in tumour immunity Nat Rev Immunol 3 427 432 1:CAS:528: DC%2BD3sXjvF2mtL4%3D 10.1038/nri1089 12766764 (Pubitemid 37323202)
19. S Nizar J Copier B Meyer M Bodman-Smith C Galustian D Kumar, et al. 2009 T-regulatory cell modulation: the future of cancer immunotherapy? Br J Cancer 100 1697 1703 1:CAS:528:DC%2BD1MXmsVChtbc%3D 10.1038/sj.bjc.6605040 19384299
20. N Pakravan H Soleimanjahi ZM Hassan 2010 GP96 C-terminal improves Her2/neu DNA vaccine J Gene Med 12 345 353 1:CAS:528:DC%2BC3cXmtFOgtrY%3D 10.1002/jgm.1445 20232284
21. Pakravan N, Soudi S, Hassan ZM (2010b) N-terminally fusion of Her2/neu to HSP70 decreases efficiency of Her2/neu DNA vaccine. Cell Stress Chap (in press)
22. SM Pupa E Tagliabue S Menard A Anichini 2005 HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine J Cell Physiol 205 10 18 1:CAS:528:DC%2BD2MXhtVSktbvE 10.1002/jcp.20387 15887236 (Pubitemid 41262846)
23. UK Rapp SH Kaufmann 2004 DNA vaccination with gp96-peptide fusion proteins induces protection against an intracellular bacterial pathogen Int Immunol 16 597 605 1:CAS:528:DC%2BD2cXisF2murs%3D 10.1093/intimm/dxh064 15039390 (Pubitemid 38489434)
24. S Rovero A Amici ED Carlo R Bei P Nanni E Quaglino, et al. 2000 DNA vaccination against rat Her-2/neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice J Immunol 165 5133 5142 1:CAS:528:DC%2BD3cXnvVOntr8%3D 11046045
25. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor: New York, pp 138-141 and 159-161
26. DJ Slamon W Godolphin LA Jones JA Holt SG Wong DE Keith, et al. 1989 Studies of the Her-2/neu proto-oncogene in human breast and ovarian cancer Science 244 707 712 1:STN:280:DyaL1M3kt1Wntg%3D%3D 10.1126/science.2470152 2470152
27. M Spadaro E Ambrosino M Iezzi E Di Carlo P Sacchetti C Curcio, et al. 2005 Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity Clin Cancer Res 11 1941 1952 1:CAS:528: DC%2BD2MXitVKrsb4%3D 10.1158/1078-0432.CCR-04-1873 15756020 (Pubitemid 40471860)
28. P Srivastava 2002 Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses Annu Rev Immunol 20 395 425 1:CAS:528:DC%2BD38XjtlWgtLo%3D 10.1146/annurev.immunol.20.100301.064801 11861608 (Pubitemid 34293430)
29. R Stan JD Wolchok AD Cohen 2006 DNA vaccines against cancer Hematol Oncol Clin N Am 20 613 636 10.1016/j.hoc.2006.02.004 (Pubitemid 44177422)
30. WZ Wei WP Shi A Galy D Lichlyter S Hernandez B Groner, et al. 1999 Protection against mammary tumor growth by vaccination with full length, modified human ErbB-2 DNA Int J Cancer 81 748 754 1:CAS:528:DyaK1MXjtF2ktL0%3D 10.1002/(SICI)1097-0215(19990531)81:5<748::AID-IJC14>3.0.CO;2-6 10328228 (Pubitemid 29214385)